This inventor holds 1 USPTO granted patent. Top assignee: Veb Fahlberg-List Chemische Und Pharmazeutische Fabriken. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Walter Furst: Innovator in Pharmaceutical Bioavailability
Introduction
Walter Furst is a notable inventor based in Halle-Neustadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the bioavailability of active ingredients in drug formulations. His innovative approach has the potential to improve the effectiveness of oral medications.
Latest Patents
Walter Furst holds a patent for a composition and methods aimed at providing optimum bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenoxime (HMLO). This patent focuses on improving the absorption of HMLO by incorporating bile acids into the pharmaceutical preparation. The use of bile acids, such as desoxycholic acid or dehydrocholic acid, significantly enhances the drug's effectiveness when administered orally.
Career Highlights
Walter Furst has dedicated his career to advancing pharmaceutical sciences. He is associated with Veb Fahlberg-List Chemische und Pharmazeutische Fabriken, where he has been instrumental in research and development efforts. His work has led to innovative solutions that address challenges in drug delivery and absorption.
Collaborations
Walter has collaborated with notable colleagues, including Gunter Voigt and Lothar Lucke. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.
Conclusion
Walter Furst's contributions to pharmaceutical innovation, particularly in enhancing drug bioavailability, highlight his role as a key inventor in the industry. His work continues to influence the development of more effective medications.